Innovator U.S. Equity Ultra Buffer ETF - November financials
$41.36−0.24%
Close Sep 28, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY26 Mar 31 | FY25 Mar 31 | FY24 Mar 31 | FY23 Mar 31 | FY22 Mar 31 | FY21 Mar 31 | FY20 Mar 31 |
|---|---|---|---|---|---|---|---|
| Revenue | $35.7M | $33.1M | $12.0M | $48.5K | $14.1K | $140.9K | $526.1K |
| Gross profit | $25.5M | $24.3M | $7.8M | $22.1K | -$8.5K | $39.9K | $218.5K |
| Gross margin | 71.4% | 73.4% | 65.5% | 45.4% | −60.3% | 28.3% | 41.5% |
| Operating income | $3.3M | $3.4M | $892.3K | -$936.7K | -$226.7K | -$4.3M | -$908.6K |
| Net income | $3.6M | $3.3M | $812.1K | -$365.4K | $3.2M | -$4.4M | -$1.2M |
| Net margin | 10.2% | 9.8% | 6.8% | −752.8% | 22468.7% | −3110.8% | −228.1% |
| Diluted EPS | $0.01 | $0.01 | $0.00 | $0.00 | $0.06 | $-0.08 | $-0.03 |
| EBITDA | $3.8M | $3.8M | $2.8M | -$919.2K | -$226.7K | -$430.7K | -$816.6K |
| Operating cash flow | $1.9M | $4.4M | $1.2M | -$1.0M | -$168.1K | -$196.7K | -$518.6K |
| Free cash flow | $1.0M | $3.2M | $1.2M | -$1.0M | -$168.1K | — | -$518.6K |
| Diluted shares | 293.1M | 303.5M | 309.7M | 145.9M | 53.9M | 53.9M | 50.9M |
Balance sheet
| Period end | Mar 31 | Mar 31 | Mar 31 | Mar 31 | Mar 31 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $796.8K | $1.5M | $697.7K | $35.8K | $26.9K | $16.2K |
| Short-term investments | $1.4M | $645.4K | $0.00 | $0.00 | $0.00 | — |
| Total debt | $0.00 | $241.5K | $91.2K | $809.2K | $780.7K | $616.4K |
| Total assets | $9.0M | $7.1M | $3.9M | $2.7M | $76.9K | $64.6K |
| Total liabilities | $1.9M | $3.2M | $1.6M | $1.6M | $1.9M | $5.1M |
| Shareholders' equity | $7.0M | $3.9M | $2.2M | $1.1M | -$1.8M | -$5.0M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology